Adam Knight

Adam Knight

Consulente / Consigliere presso Perceptive Advisors (Private Equity)

Consumer Services
Finance
Commercial Services

Provenienza dei contatti di primo grado di Adam Knight

EntitàTipo di entitàSettore Industriale
University of Cambridge
243
College/University Other Consumer Services 243
29
Subsidiary Investment Managers 29
5
Holding Company Internet Software/Services 5
3
Holding Company Miscellaneous Commercial Services 3

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Adam Knight tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
PFIZER, INC. Pharmaceuticals: Major

Douglas Giordano

Mario David Saltarelli

Corporate Officer/Principal

Corporate Officer/Principal

MORGAN STANLEY Investment Managers

Timothy Khoury

Rauf Khan

Corporate Officer/Principal

Private Equity Analyst

Miscellaneous Commercial Services

Frederick Callori

Corporate Officer/Principal

Investment Banks/Brokers

Nick Baker

Piotr Krupa

Analyst-Equity

Corporate Officer/Principal

Investment Managers

Joseph Edelman

Michael Altman

Adam Stone

Craig Yeshion

Hossein Ekrami

Ellen Hukkelhoven

Harry Jenq

Keyvan Mirsaeedi-Farahani

Sean S Mansoory

Kunal Kandimalla

Takeru Furuya

Chief Executive Officer

Analyst-Fixed Income

Chief Investment Officer

Analyst-Equity

Analyst-Equity

Analyst-Equity

Private Equity Investor

Analyst-Equity

Analyst-Fixed Income

Analyst-Equity

Analyst-Equity

Biotechnology

Sam Hall

Mario David Saltarelli

Director/Board Member

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Konstantin Poukalov

Patrick Morrow

Corporate Officer/Principal

Private Equity Investor

Investment Managers

Fei Teng

Helena Miles

Analyst-Equity

Analyst-Equity

College/University

Harry Jenq

Samuel Bjork

Takeru Furuya

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

Craig Yeshion

Keyvan Mirsaeedi-Farahani

Kunal Kandimalla

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of Oxford College/University

Xiao Zheng Jin

Samuel Bjork

Graduate Degree

Graduate Degree

Investment Managers

Harry Simpson

Jamie Gilbert

Private Equity Investor

Private Equity Investor

Investment Managers

Rui Yang Ang

Sam Williams

Private Equity Analyst

Director/Board Member

Investment Managers

Rory Nath

Laura Morrill

Faye Maughan

Private Equity Investor

Private Equity Investor

Private Equity Investor

Investment Managers

Robin Senivassen

Private Equity Investor

Columbia College (California) College/University

Orly Mishan

Undergraduate Degree

Princeton University College/University

Sam Hall

Adam Stone

Ellen Hukkelhoven

Harry Jenq

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Banks/Brokers

Fei Teng

Tej Sthankiya

Analyst-Equity

Analyst-Equity

State University of New York at Binghamton College/University

Frederick Callori

Undergraduate Degree

BIOASIS TECHNOLOGIES INC. Biotechnology

Nancy E. Stagliano

Mario David Saltarelli

Director/Board Member

Director/Board Member

Adams Street Partners UK LLP Investment Managers

Mustafa Salih

Alexander Silver

Private Equity Investor

Private Equity Investor

Medical Specialties

Orly Mishan

Director/Board Member

Boston University School of Law College/University

Frederick Callori

Graduate Degree

LYRA THERAPEUTICS, INC. Pharmaceuticals: Major

Michael Altman

Konstantin Poukalov

Director/Board Member

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Kunal Kandimalla

Timothy Khoury

Masters Business Admin

Masters Business Admin

Harvard Business School College/University

Mark McDade

Keyvan Mirsaeedi-Farahani

Masters Business Admin

Masters Business Admin

Rutgers University, Camden College/University

Peter Fierro

Samuel Cohn

Undergraduate Degree

Masters Business Admin

Investment Managers

Laura Morrill

Private Equity Investor

COGNETIVITY NEUROSCIENCES LTD. Biotechnology

Thomas Sawyer

Mark Phillips

Director of Finance/CFO

Compliance Officer

Investment Managers

Orly Mishan

Private Equity Investor

Medical Specialties

Orly Mishan

Director/Board Member

Biotechnology

Thomas Sawyer

Mark Phillips

Director/Board Member

Chairman

LANDOS BIOPHARMA, INC. Biotechnology

Christopher Garabedian

Konstantin Poukalov

Frederick Callori

Chairman

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Christopher Garabedian

Joseph Edelman

Adam Stone

Frederick Callori

Takeru Furuya

Gianna Hoffman-Luca

Chief Executive Officer

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Frederick Callori

Director/Board Member

Pharmaceuticals: Major

Christopher Garabedian

Frederick Callori

Director/Board Member

Director/Board Member

Investment Managers

David Duvenaud

Consultant / Advisor

Pharmaceuticals: Major

Christopher Garabedian

Frederick Callori

Director/Board Member

Director/Board Member

CEREVEL THERAPEUTICS HOLDINGS, INC. Pharmaceuticals: Major

Douglas Giordano

Orly Mishan

Director/Board Member

Corporate Officer/Principal

LIANBIO Biotechnology

Adam Stone

Konstantin Poukalov

Chief Executive Officer

Founder

ARYA SCIENCES ACQUISITION CORP IV Financial Conglomerates

Joseph Edelman

Michael Altman

Adam Stone

Konstantin Poukalov

Founder

Founder

Founder

Founder

ARYA SCIENCES ACQUISITION CORP V Financial Conglomerates

Joseph Edelman

Michael Altman

Adam Stone

Konstantin Poukalov

Founder

Founder

Founder

Founder

Pharmaceuticals: Major

Nancy E. Stagliano

Kathy Dong

Chairman

Chief Executive Officer

Biotechnology

Nancy E. Stagliano

Kathy Dong

Chairman

Chief Operating Officer

Statistiche

Distribuzione geografica

Stati Uniti 34
Regno Unito 11
Canada 4
Paesi Bassi 2
Hong Kong 2

Settori

Finance 22
Health Technology 18
Consumer Services 11
Commercial Services 2

Posizioni

Director/Board Member 157
Undergraduate Degree 81
Corporate Officer/Principal 72
Private Equity Investor 69
Founder 43
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA